H

Hermes-Epitek

Asia, T'ai-wan, Taiwan, Hsinchu

Description

Hermes-Epitek provides semiconductor and optoelectronic manufacturing process equipment, technical services, and parts sales.

Investor Profile

Hermes-Epitek has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (33%)
  • Series A (33%)
  • Series C (33%)

Country Focus

  • United Kingdom (67%)
  • United States (33%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Therapeutics
  • Advanced Materials
  • Computer
  • Consumer Electronics
  • Electronics
  • Industrial
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hermes-Epitek frequently co-invest with?

BACKED VC
Europe, England, United Kingdom, London
Co-Investments: 2
EIT Health
Europe, Bayern, Germany, Munich
Co-Investments: 1
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Apollo Health Ventures
Europe, Hamburg, Germany, Hamburg
Co-Investments: 1
Lifeforce Capital
North America, California, United States, San Francisco
Co-Investments: 1
Hoxton Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
A
Europe, Dublin, Ireland, Dublin
Co-Investments: 1
Selvedge Venture
Europe, England, United Kingdom, London
Co-Investments: 2
LifeLink Ventures
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 2

Which angels does Hermes-Epitek often collaborate with?

AZ
North America, California, United States, San Francisco
Shared Deals: 1
KF
North America, California, United States, San Francisco
Shared Deals: 1
MC
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Hermes-Epitek?

Ochre Bio

Oxford, Oxfordshire, United Kingdom

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AOct 10, 2022
Amount Raised: $30,000,000
Ochre Bio

Oxford, Oxfordshire, United Kingdom

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

BiopharmaBiotechnologyHealth CareTherapeutics
SeedJun 16, 2021
Amount Raised: $9,600,000
Halio

Hayward, California, United States

Halio is developing adaptive, dynamic glass for the commercial, residential, and automotive markets.

Advanced MaterialsComputerConsumer ElectronicsElectronicsIndustrialManufacturingReal EstateSmart BuildingSmart Cities
Series CJan 31, 2017
Amount Raised: $65,000,000